In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Clorazil Drug Master File in Korea (Clorazil KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Clorazil. The MFDS reviews the Clorazil KDMF as part of the drug registration process and uses the information provided in the Clorazil KDMF to evaluate the safety and efficacy of the drug.
After submitting a Clorazil KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Clorazil API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Clorazil suppliers with KDMF on PharmaCompass.